Genome (XKRX:314130) Long-Term Capital Lease Obligation : ₩3,764 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Genome Long-Term Capital Lease Obligation?

Genome's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩3,764 Mil.

Genome's quarterly Long-Term Capital Lease Obligation declined from Jun. 2023 (₩4,433 Mil) to Sep. 2023 (₩4,294 Mil) and declined from Sep. 2023 (₩4,294 Mil) to Dec. 2023 (₩3,764 Mil).

Genome's annual Long-Term Capital Lease Obligation increased from Dec. 2020 (₩1,179 Mil) to Dec. 2021 (₩5,243 Mil) but then declined from Dec. 2021 (₩5,243 Mil) to Dec. 2022 (₩4,267 Mil).

Genome Long-Term Capital Lease Obligation Historical Data

The historical data trend for Genome's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genome Long-Term Capital Lease Obligation Chart

Genome Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Long-Term Capital Lease Obligation

40.73

1,131.65

1,178.98

5,242.62

4,267.48

Genome Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial												4,267.48	4,661.86	4,433.45	4,294.42	3,764.05

Genome (XKRX:314130) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Genome Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Genome's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Genome (XKRX:314130) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genome & Co (XKRX:314130) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Innovalley A-801, Pangyo-ro 253, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486

Website

http://www.genomecom.co.kr

Genome & Co is a Korean company engaged in researching and developing dietary supplements, cosmeceuticals, and new drugs. Its products pipeline includes immunooncology therapeutic supplement for treatment of immuno-oncology, lung cancer, colorectal cancer, stomach cancer, breast cancer, pancreatic cancer; dietary supplements for treating obesity and diabetes; cosmetics used for acne and atopic dermatitis; and also produces In Virto fertilization medicine.

Genome (XKRX:314130) Headlines

No Headlines